Published in Cancer Weekly, August 11th, 2009
In May, Medco Health Solutions, Inc. (NYSE:MHS) and Indiana University School of Medicine released a study revealing that women using tamoxifen to prevent a recurrence of breast cancer who also use certain selective serotonin reuptake inhibitors (SSRI), for example Prozac (fluoxetine), Paxil (paroxetine) and Zoloft (sertraline), have up to twice the chance of having a recurrence of the disease.
In a separate New Jersey-specific analysis, Medco found that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.